Delhi: Private hospitals roped in for dialysis scheme

NEW DELHI: The Delhi government has tied up with seven private hospitals for its free dialysis scheme.

The hospitals — Maharaja Agrasen Hospital in Punjabi Bagh, Park Hospital in Meera Bagh, Dharamshila Narayana Hospital in Dallupura, Brahm Shakti Hospital in Budh Vihar, Mata Chanan Devi Hospital in Janakpuri, Kalra Hospital in Kirti Nagar and MSG Hospital in west Punjabi Bagh —have 101 dialysis machines.

A senior official said free dialysis will be provided to patients whose annual income is below Rs 3 lakh and have been residing in Delhi for the past three years.

“There is a scarcity of dialysis facility at public hospitals. The poor or even lower middle- class patients afflicted with kidney failure necessitating dialysis cannot afford private facility. The government scheme will help them,” the official added.

Sources said talks are on with more private facilities for a tie-up under which the state will pay the hospital at CGHS rate.

  • Related Posts

    MNCs seek restart of refurbished medical device imports

    New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request…

    Kerala’s Disease Surge Tied to Poor Hygiene and Climate Stress

    Thiruvananthapuram, August 19, 2025 — Kerala is seeing a sharp rise in communicable diseases as poor sanitation, stagnant water, and changing weather patterns create ideal conditions for outbreaks. Public-health experts…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    US market to dent India pharma earnings even as domestic growth remains firm

    US market to dent India pharma earnings even as domestic growth remains firm

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg